<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01320384</url>
  </required_header>
  <id_info>
    <org_study_id>FLORALI</org_study_id>
    <nct_id>NCT01320384</nct_id>
  </id_info>
  <brief_title>Clinical Effect of the Association of Noninvasive Ventilation and High Flow Nasal Oxygen Therapy in Resuscitation of Patients With Acute Lung Injury (FLORALI Study)</brief_title>
  <acronym>FLORALI</acronym>
  <official_title>Clinical Effect of the Association of Noninvasive Ventilation and High Flow Nasal Oxygen Therapy in Resuscitation of Patients With Acute Lung Injury. A Randomised Study (FLORALI Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Poitiers University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Poitiers University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to compare, in patients with acute respiratory failure/acute lung
      injury the efficacy of three different methods of oxygenation to prevent endotracheal
      intubation :

        1. conventional oxygen therapy (O2 conventional)

        2. high flow nasal oxygen therapy (O2-HFN)

        3. association of high flow nasal oxygen therapy with non invasive positive pressure
           ventilation (O2-HFN/NPPV).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">July 2013</completion_date>
  <primary_completion_date type="Actual">July 2013</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To compare the number of patients in each group who require endotracheal intubation with mechanical ventilation</measure>
    <time_frame>at day 28</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>mechanical ventilation-free to day 28</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU morbidity</measure>
    <time_frame>at day 28</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">313</enrollment>
  <condition>Acute Lung Injury</condition>
  <condition>Acute Respiratory Failure</condition>
  <arm_group>
    <arm_group_label>O2 conventional : standard low flow therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>in order to obtain a SpO2&gt;92%</description>
  </arm_group>
  <arm_group>
    <arm_group_label>O2-HNF : high flow nasal oxygen therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>set between 30 to 50 l/min,adjusted in order to obtain a SpO2 &gt;92%.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>O2-HFN/NPPV</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>cycling of NIV and O2-HDN</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>O2 conventional</intervention_name>
    <description>standard low flow therapy</description>
    <arm_group_label>O2 conventional : standard low flow therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>O2-HFN : high flow nasal oxygen therapy</intervention_name>
    <description>The patient will receive high flow nasal of humidified oxygen, set between 30 to 50 l/min. The inspired fraction of oxygen (FiO2) will be adjusted in order to obtain a SpO2 &gt;92%.</description>
    <arm_group_label>O2-HNF : high flow nasal oxygen therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>O2-HFN/NPPV : association of high flow nasal oxygen therapy and non invasive positive pressure ventilation</intervention_name>
    <description>The patient will receive successively in a day NPPV and O2-HFN. The NPPV will be applied with an airway humidification achieved by using a heated humidifier and a facial mask adapted to the morphology of the patient. The settings will be adjusted as follow : an inspiratory pressure between 6 to 14 cmH2O, in order to obtain a tidal volume between 7 to 10 ml/kg of predicted weight, a positive expiratory pressure between 0 to 10 cmH2O in order to obtain a SpO2 &gt;92% with the minimal FiO2.</description>
    <arm_group_label>O2-HFN/NPPV</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hypoxemic and no hypercapnic acute respiratory failure :

          -  severe dyspnea at rest with a respiratory rate &gt;25 breaths/min

          -  PaO2/FiO2 &lt;300

          -  PaCO2 &lt;45 mmHg,

        Exclusion Criteria:

          -  age &lt;18 years

          -  NPPV contraindications

          -  past history of respiratory chronic disease (COPD, cystic fibrosis…)

          -  cardiac pulmonary edema

          -  Pre-defined intubation

          -  other than respiratory organ failure : systolic pressure &lt;90 mmHg,current treatment
             with epinephrine or norepinephrine, decreased level of consciousness ( Glasgow score ≤
             12)

          -  profound aplasia (white cells count &lt;1000/mm 3)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Poitiers University Hospital</name>
      <address>
        <city>Poitiers</city>
        <zip>86021</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 7, 2010</study_first_submitted>
  <study_first_submitted_qc>March 21, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 22, 2011</study_first_posted>
  <last_update_submitted>October 10, 2016</last_update_submitted>
  <last_update_submitted_qc>October 10, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 11, 2016</last_update_posted>
  <responsible_party>
    <name_title>Poitiers university hospital</name_title>
    <organization>CHU Poitiers</organization>
  </responsible_party>
  <keyword>ALI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Lung Injury</mesh_term>
    <mesh_term>Acute Lung Injury</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

